These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35762736)

  • 1. Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies.
    Agarwal G; Hajra A; Chakraborty S; Patel N; Biswas S; Adler MK; Lavie CJ
    Ther Adv Cardiovasc Dis; 2022; 16():17539447221105013. PubMed ID: 35762736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.
    Hasan SS; Radford S; Kow CS; Zaidi STR
    J Thromb Thrombolysis; 2020 Nov; 50(4):814-821. PubMed ID: 32748122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
    Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.
    Llitjos JF; Leclerc M; Chochois C; Monsallier JM; Ramakers M; Auvray M; Merouani K
    J Thromb Haemost; 2020 Jul; 18(7):1743-1746. PubMed ID: 32320517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
    Cohen SL; Gianos E; Barish MA; Chatterjee S; Kohn N; Lesser M; Giannis D; Coppa K; Hirsch JS; McGinn TG; Goldin ME; Spyropoulos AC;
    Thromb Haemost; 2021 Aug; 121(8):1043-1053. PubMed ID: 33472255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019.
    Liu Y; Cai J; Wang C; Jin J; Qu L
    J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1099-1111.e6. PubMed ID: 33529719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in COVID-19: A systematic review and meta-analysis.
    Kollias A; Kyriakoulis KG; Lagou S; Kontopantelis E; Stergiou GS; Syrigos K
    Vasc Med; 2021 Aug; 26(4):415-425. PubMed ID: 33818197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19.
    Lu YF; Pan LY; Zhang WW; Cheng F; Hu SS; Zhang X; Jiang HY
    Int J Infect Dis; 2020 Nov; 100():34-41. PubMed ID: 32798659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
    Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
    Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis.
    Sarfraz A; Sarfraz Z; Razzack AA; Patel G; Sarfraz M
    Clin Appl Thromb Hemost; 2021; 27():1076029621993573. PubMed ID: 33571009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in Black COVID-19 patients in a minority context compared to White, Asian and other racialized patients: A systematic review and meta-analysis.
    Cénat JM; Dromer E; Farahi SMMM; Ndamage CM; Yun A; Zuta H; Mkhatri J; Samson E; Barara R; Labelle PR; Xu Y
    Thromb Res; 2024 Jun; 238():197-205. PubMed ID: 38733691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
    Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
    J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Venous Thromboembolism in Severe COVID-19: A Study-Level Meta-Analysis of 21 Studies.
    Lobbes H; Mainbourg S; Mai V; Douplat M; Provencher S; Lega JC
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of anticoagulation in lowering the mortality in hospitalized covid-19 patients: Meta-analysis of available literature.
    Aamir Waheed M; Rashid K; Rajab T; Rajab A; Adnan AH; Fayyaz H; Ibad AA; Basri R; Khan Y; Alhabib HI; Elzouki A
    Saudi Med J; 2022 Jun; 43(6):541-550. PubMed ID: 35675936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolic events in patients with COVID-19: a systematic review and meta-analysis.
    Wu T; Zuo Z; Yang D; Luo X; Jiang L; Xia Z; Xiao X; Liu J; Ye M; Deng M
    Age Ageing; 2021 Feb; 50(2):284-293. PubMed ID: 33201226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A narrative review on the epidemiology, prevention, and treatment of venous thromboembolic events in the context of chronic venous disease.
    Kemp MT; Obi AT; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1557-1567. PubMed ID: 33866055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.